Clincosm LogoSign in Get a demo

Mucopolysaccharidosis II

Showing 26 - 32 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hunter Syndrome, Mucopolysaccharidosis II, MPS II Trial in Porto Alegre, Warsaw, Taipei (Idursulfase)

Completed
Has Results
  • Hunter Syndrome
  • +2 more
  • Idursulfase
  • Porto Alegre, RS, Brazil
  • +2 more
May 14, 2021

Biomarkers for Hunter Syndrome

Active, not recruiting
  • Hunter Syndrome
  • +3 more
    • Cancun, Quintana Roo, Mexico
    • +3 more
    May 12, 2021

    Mucopolysaccharidosis II Trial in Germany, Philippines, United States (AGT-182)

    Completed
    • Mucopolysaccharidosis II
    • Oakland, California
    • +4 more
    Sep 16, 2018

    Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI Trial in Minneapolis (Somatropin (DNA origin))

    Terminated
    Has Results
    • Mucopolysaccharidosis I
    • +2 more
    • Somatropin (DNA origin)
    • Minneapolis, Minnesota
      University of Minnesota
    Aug 6, 2018

    Test Possibility of Cross Reaction Induced by Idursulfase Drug

    Completed
    • Mucopolysaccharidosis II
    • Tokyo, Japan
      GSK Investigational Site
    Sep 21, 2017

    Detect Unrecognized Mucopolysaccharidosis in Children Visiting

    Terminated
    • Mucopolysaccharidoses
    • +4 more
    • Dried blood spot test for MPS
    • New Brunswick, New Jersey
    • +1 more
    May 23, 2013

    Mucopolysaccharidosis II Trial in Minneapolis (lymphocyte gene therapy)

    Completed
    • Mucopolysaccharidosis II
    • lymphocyte gene therapy
    • Minneapolis, Minnesota
      University of Minnesota Medical School
    Jun 23, 2005